Dabigatran is a direct thrombin inhibitor used as an anticoagulant to prevent blood clots and stroke.
Dabigatran belongs to a class of medicines known as direct oral anticoagulants. It works by stopping a key protein in the blood-clotting process, which helps to keep clots from forming. In Hong Kong, dabigatran is most commonly found in the prescription product Pradaxa.
The principal product that contains dabigatran in Hong Kong is Pradaxa, supplied as oral capsules. It is available in two strength options - 110 mg and 150 mg - allowing doctors to match the dose to a patient’s specific needs. While Pradaxa is the branded form, the underlying active ingredient, dabigatran etexilate, may also appear in generic versions that are approved by the Hong Kong Department of Health and the Pharmacy and Poisons Board. The capsules are usually taken with water and can be swallowed whole.
These uses are approved by the Hong Kong health authorities and reflect the medication’s role in managing conditions where abnormal clotting is a concern.
Dabigatran directly blocks the activity of thrombin, a protein that converts fibrinogen into fibrin-a key step in clot formation. By inhibiting this step, the drug reduces the ability of blood to clot, which helps to prevent new clots and the growth of existing ones. The effect begins soon after the capsule is swallowed, providing reliable protection without the need for routine blood-test monitoring.
Most people experience only mild, short-lasting reactions. Typical reports include:
These symptoms usually resolve on their own and do not require medical attention.
Although rare, some reactions need urgent care:
If any of these signs appear, seek emergency assistance immediately.
Certain health situations warrant extra care with dabigatran:
People with known hypersensitivity to dabigatran or any component of the capsule should avoid it.
Dabigatran can interact with other medicines and lifestyle factors:
For a complete interaction list, refer to the specific medication’s detailed information.
Store Pradaxa capsules at room temperature, away from moisture and direct sunlight. The treatment period can vary-from short-term use after a clot event to long-term prevention for chronic conditions. Because different dabigatran products may have distinct strengths or formulation details, always read the accompanying patient information leaf-let. For detailed usage, dosing, and administration, refer to your specific medication’s information.
Thrombin: A protein that helps turn blood fluid into a clot.
Atrial fibrillation: An irregular heartbeat that can lead to clot formation in the heart.
Deep-vein thrombosis (DVT): A blood clot that develops in a deep vein, usually in the leg.
Pulmonary embolism (PE): A blockage in a lung artery caused by a clot that traveled from elsewhere in the body.
This article offers general educational information about dabigatran as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing dabigatran may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
